Personal and social performance in schizophrenia: double-blind, non-inferiority study of once-monthly vs oral aripiprazole

被引：1
|
作者：
Fleischhacker, W. W. [1 ]
Sanchez, R. [2 ]
Jin, N. [3 ]
Peters-Strickland, T. [2 ]
Johnson, B. R. [4 ]
Eramo, A. [5 ]
Loze, J. Y. [6 ]
McQuade, R. D. [7 ]
Carson, W. H. [8 ]
Kane, J. [9 ,10 ]
机构：
[1] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Global Clin Dev CNS, Princeton, NJ USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Biostat, Rockville, MD USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[5] H Lundbeck & Co AS, Med Affairs & Phase Clin Affairs 4, Deerfield, IL USA
[6] Otsuka Pharmaceut Europe Ltd, European CNS Market Access, London, England
[7] Otsuka Pharmaceut Dev & Commercializat Inc, Global Med Regulatory Affairs & Alliances, Princeton, NJ USA
[8] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[9] Zucker Hillside Hosp, Glen Oaks, NY USA
[10] Hofstra North Shore LIJ Sch Med, Dept Psychiat, Glen Oaks, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70751-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.028
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [41] The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
    Peters-Strickland, Timothy
    Baker, Ross A.
    Such, Pedro
    Zhang, Peter
    Madera, Jessica J.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1659 - 1669
  • [42] Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
    Sanchez-Gistau, Vanessa
    Moreno, Maria Jose
    Gomez-Lus, Susana
    Sicras-Mainar, Antoni
    Crespo-Facorro, Benedicto
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [43] The efficacy and safety of aripiprazole once-monthly in obese and non-obese patients with schizophrenia; a post-hoc analysis
    Eramo, A.
    De Hert, M.
    Landsberg, W.
    Tsai, L. -F.
    Baker, R. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 69 - 69
  • [44] THE EFFECT OF PREVIOUS DOSE OR ORAL ARIPIPRAZOLE (10 OR 30 MG/DAY) ON THE EFFICACY AND TOLERABILITY OF ARIPIPRAZOLE ONCE-MONTHLY: RESULTS FROM POST-HOC ANALYSES FROM TWO DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIALS
    Baker, Ross A.
    Eramo, Anna
    Nylander, Anna-Greta
    Tsai, Lan-Feng
    Peters-Strickland, Timothy S.
    Kostic, Dusan
    Sanchez, Raymond
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S293 - S293
  • [45] Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study
    Kane, J. M.
    Zhao, C.
    Johnson, B.
    Baker, R. A.
    Eramo, A.
    McQuade, R. D.
    Duca, A.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S549 - S550
  • [46] A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
    Fleischhacker, W. Wolfgang
    McQuade, Robert D.
    Marcus, Ronald N.
    Archibald, Donald
    Swanink, Rene
    Carson, William H.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (06) : 510 - 517
  • [47] A PLACEBO-CONTROLLED STUDY OF EFFICACY AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR LONG-TERM MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Eramo, A.
    Fleischhacker, W. W.
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    McQuade, R. D.
    Carson, W. H.
    Kane, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [48] A DOUBLE-BLIND, NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL OF TRANSVAGINAL PROCEDURES FOR THE REPAIR OF A RECTOCELE
    Henn, E. W.
    Richter, B. W.
    Burger, D. A.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 : S31 - S32
  • [49] Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
    Ljostad, Unn
    Skogvoll, Eirik
    Eikeland, Randi
    Midgard, Rune
    Skarpaas, Tone
    Berg, Ase
    Mygland, Ase
    LANCET NEUROLOGY, 2008, 7 (08): : 690 - 695
  • [50] TREATMENT PATTERNS AND MEDICAID SPENDING IN COMORBID SCHIZOPHRENIA POPULATIONS: ONCE-MONTHLY PALIPERIDONE PALMITATE VS ORAL ATYPICAL ANTIPSYCHOTICS
    Kamstra, R.
    Pilon, D.
    Lefebvre, P.
    Emond, B.
    Joshi, K.
    VALUE IN HEALTH, 2018, 21 : S180 - S180
12345